Opko HEALTH, Inc. (OPK) intrinsic value & 10-year financials
Opko HEALTH, Inc. (OPK) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 10 fiscal years revenue shrank 6.6% a year to $606.9M, with an average return on invested capital of -8.1%.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $1.53
- Market cap
- $1.1B
- Revenue (FY2025)
- $606.9M
- Revenue growth (10-yr CAGR)
- -6.6%
- ROIC (10-yr avg)
- -8.1%
- Free cash flow (FY2025)
- -$190.8M
OPK 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $606.9M | -$225.7M | -$0.30 | -$190.8M | -19.3% | -9.2% |
| FY2024 | $713.1M | -$53.2M | -$0.08 | -$208.5M | -21.3% | -10.9% |
| FY2023 | $863.5M | -$188.9M | -$0.25 | -$44.5M | -18.2% | -11.1% |
| FY2022 | $1.0B | -$328.4M | -$0.46 | -$119.8M | -22.5% | -11.7% |
| FY2021 | $1.8B | -$30.1M | -$0.05 | $6.2M | 1.1% | 1.1% |
| FY2020 | $1.4B | $30.6M | $0.05 | $5.8M | 4.0% | 2.3% |
| FY2019 | $901.9M | -$314.9M | -$0.53 | -$185.3M | -30.4% | -16.8% |
| FY2018 | $990.3M | -$153.0M | -$0.27 | -$137.0M | -17.3% | -7.9% |
| FY2017 | $966.0M | -$308.9M | -$0.55 | -$138.6M | -29.0% | -15.3% |
| FY2016 | $1.1B | -$25.1M | -$0.10 | $13.5M | -6.6% | -1.9% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
OPKO HEALTH, INC. is facing top-line stagnation, with revenue contracting over the decade.
OPKO HEALTH, INC. has historically struggled to out-earn its cost of capital, averaging just -8.1% ROIC.
OPKO HEALTH, INC. has not shown aggressive share repurchases (>10% retirement) or a major balance-sheet leverage increase (>50% net debt growth) over the 10-year window.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, OPKO HEALTH, INC. is modeled at -6.6% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-0.20 per share.